DUBLIN, Calif.--(BUSINESS WIRE)--Eksigent, a developer of advanced low-flow fluid delivery technologies for drug discovery and other life science applications, announced today that Kevin Sayer has been appointed to its board of directors. Sayer is a consultant to the pharmaceutical and biotech industries with expertise in medical devices and finance.
